CN1462584A - Externally-used disinfector - Google Patents
Externally-used disinfector Download PDFInfo
- Publication number
- CN1462584A CN1462584A CN 03133391 CN03133391A CN1462584A CN 1462584 A CN1462584 A CN 1462584A CN 03133391 CN03133391 CN 03133391 CN 03133391 A CN03133391 A CN 03133391A CN 1462584 A CN1462584 A CN 1462584A
- Authority
- CN
- China
- Prior art keywords
- extract
- disinfectant
- aloe
- infection
- external use
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000645 desinfectant Substances 0.000 claims abstract description 29
- 239000000284 extract Substances 0.000 claims abstract description 15
- 241000212948 Cnidium Species 0.000 claims abstract description 12
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 12
- 239000003814 drug Substances 0.000 claims description 20
- 238000005406 washing Methods 0.000 claims description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- 241000246044 Sophora flavescens Species 0.000 claims description 11
- 229940069521 aloe extract Drugs 0.000 claims description 11
- 229940064064 purslane extract Drugs 0.000 claims description 10
- 239000006210 lotion Substances 0.000 claims description 9
- NRBJWZSFNGZBFQ-UHFFFAOYSA-N 1-cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid;2-hydroxypropanoic acid Chemical compound CC(O)C(O)=O.C12=CC(N3CCNCC3)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1CC1 NRBJWZSFNGZBFQ-UHFFFAOYSA-N 0.000 claims description 8
- 229960004055 ciprofloxacin lactate Drugs 0.000 claims description 8
- 239000012153 distilled water Substances 0.000 claims description 5
- 235000011399 aloe vera Nutrition 0.000 abstract description 14
- 241001116389 Aloe Species 0.000 abstract description 13
- 230000000694 effects Effects 0.000 abstract description 11
- 239000000463 material Substances 0.000 abstract description 7
- 230000008901 benefit Effects 0.000 abstract description 2
- 230000007797 corrosion Effects 0.000 abstract description 2
- 238000005260 corrosion Methods 0.000 abstract description 2
- 230000000249 desinfective effect Effects 0.000 abstract description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 abstract 1
- 241000219784 Sophora Species 0.000 abstract 1
- 230000007794 irritation Effects 0.000 abstract 1
- 239000002574 poison Substances 0.000 abstract 1
- 231100000614 poison Toxicity 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 description 22
- 238000011282 treatment Methods 0.000 description 15
- 210000003491 skin Anatomy 0.000 description 14
- 238000000034 method Methods 0.000 description 11
- 230000001954 sterilising effect Effects 0.000 description 11
- 238000004659 sterilization and disinfection Methods 0.000 description 11
- 210000001215 vagina Anatomy 0.000 description 10
- 229940033663 thimerosal Drugs 0.000 description 9
- 239000000706 filtrate Substances 0.000 description 8
- RTKIYNMVFMVABJ-UHFFFAOYSA-L thimerosal Chemical compound [Na+].CC[Hg]SC1=CC=CC=C1C([O-])=O RTKIYNMVFMVABJ-UHFFFAOYSA-L 0.000 description 8
- 230000000844 anti-bacterial effect Effects 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 239000000843 powder Substances 0.000 description 7
- MYSWGUAQZAJSOK-UHFFFAOYSA-N ciprofloxacin Chemical compound C12=CC(N3CCNCC3)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1CC1 MYSWGUAQZAJSOK-UHFFFAOYSA-N 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 241000588724 Escherichia coli Species 0.000 description 5
- 206010046914 Vaginal infection Diseases 0.000 description 5
- 201000008100 Vaginitis Diseases 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 238000009472 formulation Methods 0.000 description 5
- 201000005630 leukorrhea Diseases 0.000 description 5
- 244000000010 microbial pathogen Species 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 206010046901 vaginal discharge Diseases 0.000 description 5
- 241000193830 Bacillus <bacterium> Species 0.000 description 4
- 238000004140 cleaning Methods 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 206010037844 rash Diseases 0.000 description 4
- 206010048946 Anal abscess Diseases 0.000 description 3
- 206010007882 Cellulitis Diseases 0.000 description 3
- 201000004624 Dermatitis Diseases 0.000 description 3
- 201000000297 Erysipelas Diseases 0.000 description 3
- 240000001624 Espostoa lanata Species 0.000 description 3
- 235000009161 Espostoa lanata Nutrition 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 208000010201 Exanthema Diseases 0.000 description 3
- 206010018612 Gonorrhoea Diseases 0.000 description 3
- 208000003251 Pruritus Diseases 0.000 description 3
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 3
- 241000191967 Staphylococcus aureus Species 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 229960003405 ciprofloxacin Drugs 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000003628 erosive effect Effects 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 201000005884 exanthem Diseases 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 206010040872 skin infection Diseases 0.000 description 3
- 201000004647 tinea pedis Diseases 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- 101100027969 Caenorhabditis elegans old-1 gene Proteins 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 241000588653 Neisseria Species 0.000 description 2
- KFSLWBXXFJQRDL-UHFFFAOYSA-N Peracetic acid Chemical compound CC(=O)OO KFSLWBXXFJQRDL-UHFFFAOYSA-N 0.000 description 2
- 241000588769 Proteus <enterobacteria> Species 0.000 description 2
- 241000607142 Salmonella Species 0.000 description 2
- 241000607768 Shigella Species 0.000 description 2
- 241000194017 Streptococcus Species 0.000 description 2
- 206010053615 Thermal burn Diseases 0.000 description 2
- 241000224527 Trichomonas vaginalis Species 0.000 description 2
- 241000607598 Vibrio Species 0.000 description 2
- 235000009754 Vitis X bourquina Nutrition 0.000 description 2
- 235000012333 Vitis X labruscana Nutrition 0.000 description 2
- 240000006365 Vitis vinifera Species 0.000 description 2
- 235000014787 Vitis vinifera Nutrition 0.000 description 2
- 206010052428 Wound Diseases 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 238000009395 breeding Methods 0.000 description 2
- 230000001488 breeding effect Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 210000001072 colon Anatomy 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N coumarin Chemical compound C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 210000002200 mouth mucosa Anatomy 0.000 description 2
- 210000004877 mucosa Anatomy 0.000 description 2
- 210000002850 nasal mucosa Anatomy 0.000 description 2
- 238000012856 packing Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 210000004927 skin cell Anatomy 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 208000013464 vaginal disease Diseases 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- 208000030507 AIDS Diseases 0.000 description 1
- 241000607528 Aeromonas hydrophila Species 0.000 description 1
- 244000144927 Aloe barbadensis Species 0.000 description 1
- 235000002961 Aloe barbadensis Nutrition 0.000 description 1
- 241001480043 Arthrodermataceae Species 0.000 description 1
- 206010069918 Bacterial prostatitis Diseases 0.000 description 1
- 208000035985 Body Odor Diseases 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 241000606161 Chlamydia Species 0.000 description 1
- 241000588923 Citrobacter Species 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 206010048768 Dermatosis Diseases 0.000 description 1
- 241000194032 Enterococcus faecalis Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 206010048461 Genital infection Diseases 0.000 description 1
- 208000009889 Herpes Simplex Diseases 0.000 description 1
- 208000007514 Herpes zoster Diseases 0.000 description 1
- 241000725303 Human immunodeficiency virus Species 0.000 description 1
- 206010021531 Impetigo Diseases 0.000 description 1
- ZSBXGIUJOOQZMP-UHFFFAOYSA-N Isomatrine Natural products C1CCC2CN3C(=O)CCCC3C3C2N1CCC3 ZSBXGIUJOOQZMP-UHFFFAOYSA-N 0.000 description 1
- 241000588748 Klebsiella Species 0.000 description 1
- ZSBXGIUJOOQZMP-JLNYLFASSA-N Matrine Chemical compound C1CC[C@H]2CN3C(=O)CCC[C@@H]3[C@@H]3[C@H]2N1CCC3 ZSBXGIUJOOQZMP-JLNYLFASSA-N 0.000 description 1
- 241000204031 Mycoplasma Species 0.000 description 1
- HPUXDMUGCAWDFW-UHFFFAOYSA-N Osthole Natural products COc1ccc2CCC(=O)Oc2c1C=CC(=O)C HPUXDMUGCAWDFW-UHFFFAOYSA-N 0.000 description 1
- 241000219295 Portulaca Species 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- 241000517304 Pthirus pubis Species 0.000 description 1
- 206010061926 Purulence Diseases 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- 241000700584 Simplexvirus Species 0.000 description 1
- 206010040904 Skin odour abnormal Diseases 0.000 description 1
- 206010062255 Soft tissue infection Diseases 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 201000005010 Streptococcus pneumonia Diseases 0.000 description 1
- 241000193998 Streptococcus pneumoniae Species 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 241001502500 Trichomonadida Species 0.000 description 1
- 241000224526 Trichomonas Species 0.000 description 1
- 208000005448 Trichomonas Infections Diseases 0.000 description 1
- 206010044620 Trichomoniasis Diseases 0.000 description 1
- 241001045770 Trichophyton mentagrophytes Species 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 208000006374 Uterine Cervicitis Diseases 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 238000005162 X-ray Laue diffraction Methods 0.000 description 1
- 241000607734 Yersinia <bacteria> Species 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 102000011759 adducin Human genes 0.000 description 1
- 108010076723 adducin Proteins 0.000 description 1
- 229940006091 aloe polysaccharide Drugs 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 210000000621 bronchi Anatomy 0.000 description 1
- 210000001217 buttock Anatomy 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 206010008323 cervicitis Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000013043 chemical agent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 210000003555 cloaca Anatomy 0.000 description 1
- 229960000956 coumarin Drugs 0.000 description 1
- 235000001671 coumarin Nutrition 0.000 description 1
- 238000005202 decontamination Methods 0.000 description 1
- 230000003588 decontaminative effect Effects 0.000 description 1
- 230000037304 dermatophytes Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 239000007938 effervescent tablet Substances 0.000 description 1
- 229940032049 enterococcus faecalis Drugs 0.000 description 1
- 230000000688 enterotoxigenic effect Effects 0.000 description 1
- 230000008472 epithelial growth Effects 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 230000036449 good health Effects 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 208000002741 leukoplakia Diseases 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 229930014456 matrine Natural products 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000004987 nonapoptotic effect Effects 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- MBRLOUHOWLUMFF-UHFFFAOYSA-N osthole Chemical compound C1=CC(=O)OC2=C(CC=C(C)C)C(OC)=CC=C21 MBRLOUHOWLUMFF-UHFFFAOYSA-N 0.000 description 1
- 239000003182 parenteral nutrition solution Substances 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 208000013223 septicemia Diseases 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- MFFIRXGJJPPAMA-QLYHWAPBSA-N ulein Chemical compound C1=CC=C2C([C@@H]3N(C)CC[C@@H](C4=C)C3CC)=C4NC2=C1 MFFIRXGJJPPAMA-QLYHWAPBSA-N 0.000 description 1
- FCWXLJIBTVFAQF-UHFFFAOYSA-N uleine Natural products CCC1C2CCN(C)C1C3C(Nc4ccccc34)C2=C FCWXLJIBTVFAQF-UHFFFAOYSA-N 0.000 description 1
- 208000000143 urethritis Diseases 0.000 description 1
- 208000019206 urinary tract infection Diseases 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
An externally-applied disinfectant for the surface of human body is prepared from cinrofloxacin lactate and the extracts of 4 Chinese-medicinal materials including portulace, cnidium fruit, flavescent sophora root and aloe. Its advantages are broad spectrum, high disinfecting power, quickly taking its high effect, no irritation, corrosion and poison.
Description
(1) technical field
The present invention relates to a kind of disinfectant, particularly relate to a kind of disinfectant for external use of Chinese and Western medicine combination with broad-spectrum bactericidal action.
(2) background technology
Good health and a long life are human eternal pursuing one's goal, and are along with the raising day by day of people's living standard, more urgent to healthy beautiful pursuit.Disease of skin, women's vaginal disease has become common disease, frequently-occurring disease, as skin infection, sore rash, erysipelas, cellulitis, tinea pedis infection, the infection of ear schneiderian membrane, oral mucosa infection, perianal abscess, diseases such as vaginitis, cervical erosion, pudendal pruritus, abnormal leucorrhea, chronic eczema, vagina peculiar smell, Trichomonas vaginalis, crab louse, leukoplakia vulvae, not only bring misery to the patient, and skin surface disease, also influence outward appearance U.S. of human body, bring stress to the patient.Methods of treatment can be divided into medicine for oral administration and externally applied drug.Medicine for oral administration is taken for a long time and is easy to damage other internal organs of human body, as liver, kidney, stomach etc.Externally applied drug has washing lotion (thimerosal), suppository etc. according to different syndromes.The thimerosal of selling in the market and using mainly is a chemical agent, and use is single, and what have can only be used as environment disinfected, the corrosion to equipment that has is very strong, as the Peracetic acid of present employing, concentration is big to have infringement to skin, and some disinfectant also has certain toxicity.
(3) summary of the invention
The technical problem to be solved in the present invention provides a kind of broad-spectrum bactericidal action that has, and skin and lesions position are not had injury, and has the disinfectant for external use of skin care effect.
The technical scheme that adopts is:
Disinfectant for external use is to be mixed by Chinese medical extract and Western medicine Ciprofloxacin lactate to be mixed with, and Chinese medical extract comprises Chinese medicine purslane extract, common cnidium fruit P.E, shrubby sophora extract, aloe extract, is powder.
Purslane extract, common cnidium fruit P.E, shrubby sophora extract, aloe extract, the Lactated compatibility of Ciprofloxacin are: purslane extract 7.5-30kg, common cnidium fruit P.E 7.5-30kg, shrubby sophora extract 5-20kg, aloe extract 5-20kg, Ciprofloxacin lactate 0.002-0.009kg.
The production method of purslane extract is:
Get the kitchen garden decontamination, input is washed and is added the water cleaning in the pond once, puts into Decocting pot after pulling out, adds clean water and covers powder, soaks 3-4 hour, adds suitable quantity of water again, and heating decocted 20-40 minute, got decoction liquor and deposited standby.In Decocting pot, add suitable quantity of water then and decoct secondary again, three decoction liquor obtaining are merged, place in the freezer and placed 24-48 hour down, take out and filter at 5-10 ℃, collect filtrate, till filtrate vacuum concentration to proportion is 1.05-1.10, atomized drying again, spray-dired EAT is 150-160 ℃, leaving air temp is 60-70 ℃, promptly get the purslane extract finished product, packing, the shady and cool dry place of sealing preserve, and be standby.
The production method of common cnidium fruit P.E is:
After getting the Chinese medicine frutus cnidii and removing its foreign material, put into Xi Chizhong and add the clean water cleaning once, pull and put into Decocting pot out, add water and cover powder, soaked 3-4 hour, heating decocted 20-40 minute, got decoction liquor, the same operation is secondary repeatedly, the decoction liquor that obtains for three times is merged, place in the freezer and placed 24-48 hour down, take out and filter at 5-10 ℃, filtrate vacuum concentration to proportion is 1.05-1.10, atomized drying again, EAT is 150-160 ℃, leaving air temp is 55-65 ℃, promptly get the common cnidium fruit P.E finished product, standby.
The production method of shrubby sophora extract is:
Getting kuh-seng soaked 3-4 hour, pull out and put into Decocting pot, supplementing water covers powder, heating decocted 20-40 minute, take out decoction liquor, the same operation three times repeatedly merges four gained decoction liquor, vacuum concentration to the stoste volume 1/3 after, in whipping process, add 95% ethanol to containing 70% concentration of alcohol, placed 24-48 hour, and removed by filter sediment, gained filtrate is carried out atomized drying, EAT is 155-165 ℃, leaving air temp is 55-65 ℃, promptly gets the shrubby sophora extract finished product, and is standby.
The manufacture method of aloe extract is:
Get fresh aloe, peeling is smashed to pieces evenly, hydraulic fluid filters, and collects filtrate, 1% adding decolorizing with activated carbon by weight refilters, and collects filtrate, vacuum concentration is about 1/10 of filtrate volume to be stopped to concentrate, with the concentrate atomized drying, EAT is 135-145 ℃, and leaving air temp is 50-60 ℃, promptly get the aloe extract finished product, standby.
Disinfectant for external use also can be made into washing lotion and makes instant effervescent tablet by pharmacy.
The manufacture method of disinfectant for external use washing lotion is:
Get kitchen garden, frutus cnidii, kuh-seng, aloe, Ciprofloxacin lactate by prescription, in continuous whipping process, add successively and be equipped with in the material-compound tank of an amount of distilled water, after treating whole medicine dissolutions, filter, in filtrate, add distilled water, make distilled water content be the medicine total amount 15-18 doubly, sampling chemical examination, qualified back packing.Can be distributed into 200mL/ bottle or 500mL/ bottle.
In the above-mentioned various formulations of disinfectant for external use, all can dose into an amount of aromatic.
The side separates:
1, the Chinese medicine kitchen garden is plant Portulaca oleraceal dry aerial parts.Contain multiple effective ingredient, as kitchen garden first, second element, coumarin etc. have effect clearing heat and detoxicating, treatment sore exanthema.
Spread on the Wound treating suppurative dermatosis outward, the various infection of surgery, bubble is washed the treatment impetigo, hip bath treatment private parts, perianal abscess, also has multiple pathogenic microorganism infection diseases such as eczema, joint are swollen, erysipelas, cellulitis, and effect is remarkable.
2, the Chinese medicine frutus cnidii is the dry mature fruit of plant Cnidium monieri (L.) Cuss, contain Osthole, firpene, amphene, volatile materials etc. have inhibitory action to multiple pathogenic microorganisms, trichomonad etc., as staphylococcus aureus, Pseudomonas aeruginosa, Trichomonas vaginalis etc.Be used for various human body skin infection, external genital infection, vaginitis, itch, gonorrhoea, trichomoniasis etc. better result of treatment is all arranged.
3, the Chinese medicine kuh-seng is the dry root of plant Sophora flavescens Ait.Contain multiple effective active components such as matrine, flavonoids.Escherichia coli, proteus, beta streptococcus, staphylococcus aureus, Pseudomonas aeruginosa all there are obvious inhibitory action, can kill trichomonas etc.Be used for various people's body surface pathogenic microorganism infections, vaginitis, gonorrhoea, cervical erosion etc. all have good efficacy.
4, the Chinese medicine aloe is the leaf of plant Aloe barbadensis Miller or Aferox Miller and homemade aloe Avera L.var.chinensis (HaW.) Berger, contain gelling class material, aloe J, aloe A, mucin (Mucin), Ah's Laue crow sieve (Aloe ulein), A Laomo chant in a loud voice effective ingredients such as (Alomiein), aloe polysaccharide.With the water-leach liquor test Escherichia coli, Pseudomonas aeruginosa, trichophyton mentagrophytes, dermatophyte etc. all there are inhibitory action, can also suppress herpes simplex virus and infection thereof.According to the literature, aloe can strengthen AIDS patient's immune system, the diffusion of blocking-up human immunodeficiency virus.Mechanism is and suppresses the synthetic of bacterial nucleic acid, and causing can not synthetic protein and make the bacterium can not growth and breeding.
Modern study shows that aloe is coated on the skin, can promote epithelial growth to subcutaneous infiltration, and non-viable non-apoptotic cell comes off, and the Skin Cell vigor is strengthened; Suppress oozing out of ulcer diffusate, the healing of accelerated in wounds is restored, and has and repairs and palingenesis.Therefore, apply body surface with aloe extract, can absorb heat anti-inflammatory, detumescence make Skin Cell become fresh soft, glossy, flexible, play the effect of skin care, like this, sterilization and skin care are combined, and be an innovation of people's body surface disinfectant, make something perfect even more perfect.
Among the people, common people directly control with aloe and burn, again Chinese aloe leaf " scald grass ", the remarkable result of treatment of visible aloe.
Above-mentioned four kinds of Chinese medicines are one edition one one of Chinese Pharmacopoeia 2000 and are written into medicinal material.
5, Ciprofloxacin (eiprofloxacin) is an extensive pedigree antibiotic.Has a good antibacterial action external, to citrobacter genus, cloaca, Escherichia coli, Klebsiella, Proteus, Salmonella, Shigella, vibrio, Yersinia, gonococcus, Bacillus influenzae, pseudomonas, staphylococcus etc.To streptococcus pneumonia, hemolytic streptococcus, enterococcus faecalis etc., sand ring Chlamydia, mycoplasma, tubercle bacillus and anonymous mycobacteria etc. all there is antibacterial activity.As a kind of bactericide, now it is generally acknowledged the A subunit of drug effect in bacterial cell DNA enzyme, suppress the synthetic of DNA and duplicate and cause bacterium death.
Clinical practice is in urogenital infections, comprise simple property, complexity urinary tract infections, bacterial prostatitis, gonococcus urethritis or cervicitis, by infection, skin soft-tissue infection due to Shigella, Salmonella, enterotoxigenic escherichia coli, aeromonas hydrophila, the vibrio parahaemolytious etc., respiratory tract, bronchi and general infections such as pulmonary infection and septicemia.
Preparation has tablet, capsule and parenteral solution, with oral or drug administration by injection.
According to in-vitro antibacterial test, to do external application and people's body surface is killed or suppressed pathogenic microorganisms, washing, sterilization infection site can be brought into play quick-acting and therapeutic action.With drug matching, to maximize favourable factors and minimize unfavourable ones, synergy strengthens sterilizing ability, becomes an outstanding new disinfectant.
Ciprofloxacin is written into two ones of Chinese Pharmacopoeia versions in 2000.
Separate disinfectant for external use of the present invention as can be known according to above-mentioned side and select medicine and compatibility science, be applicable to the sterilization usefulness of human epidermal skin, vagina mucosa, ear schneiderian membrane, oral mucosa infection site, local burn and scald etc., have the function of sterilization, cleaning, treatment and skin care.
The present invention is for prevention and tool good results such as the various skin infections of treatment, sore rash, erysipelas, cellulitis, tinea pedis infection, eczema, itch, perianal abscess, vaginitis, cervical erosion, dripping property vaginitis, gonorrhoea.
Using method:
1, the washing lotion formulation usage of disinfectant for external use:
The skin surface infection can directly be cleaned with thimerosal, or soaks thimerosal with cotton balls and clean, and also available husky cloth soaks into this thimerosal soak affected part, and morning every day, evening are respectively once.
Disinfecting private parts with thimerosal cyclic washing of the present invention repeatedly or hip bath, soaked private parts 10-15 minute, every day early, evening each once.
Vagina mucosa sterilization is raised buttocks and with syringe thimerosal 20-30mL is injected in the vagina or with containing the thimerosal cotton balls and fasten a line, places in the vagina, and line is stayed outside the vagina, and early pull out cotton balls and get final product next day, every night once, and until recovery from illness.
The infection prevention venereal disease is used, and directly all can with thimerosal washing sexual organ of the present invention or immersion.
When 2, adopting powder, can adorn diffusing deposited infection place of pulvis, or be mixed with 5% aqueous solution, adopt above-mentioned washing lotion method to treat.
Quantitative disinfection test result:
Sample: the washing lotion formulation of disinfectant for external use
(1) materials and methods
Test organisms: Escherichia coli 8099, staphylococcus aureus Atec6538 is called for short colon bacillus, golden grape.
Test method:
Undertaken by " disinfection technology standard " method
(2) assay
Quantitative disinfection test result (suspension method)
Different (min) sterilizing rate action time (%) control groups of drug use
Bacterial strain concentration (%) 5 10 CFU/mL
Colon bacillus 10 99.9300 99.9800 5.50 * 10
6
Gold grape 10 99.9500 99.9900 6.00 * 10
6
Annotate: experimental condition: neutralizer is 1.0%, Tween 80+0.5 lecithin, cleaning temp 25 ℃ ± 1
3 repeated tests, bactericidal effect meets the requirements.
Disinfectant for external use of the present invention has been carried out a large amount of clinic trial, respond well.
Infecting 87 examples with treatment vaginal disease and people's body surface is that example is explained as follows external application disinfectant result of treatment:
1, case is selected
The female patient of diplococcus, herpes simplex viral infections, private parts communicable disease are selected in human trial.
(1) a large amount of purulence sample leukorrhea body odor flavors is arranged in the vagina;
(2) microscopically is found gram-negative diplococci;
(3) the infected who has is with the pain of lower abdomen or pain in the back etc.
2, methods of treatment
Every day 1-2 time, to infection site, sterilization, observation is treated in washing and soak etc., general 1-7 time.
3, effect is judged
Drug withdrawal was observed after 4 days.
(1) recovery from illness vagina and cunnus hyperraemia disappear, and purulent leukorrhea disappears, and stink disappears;
(2) produce effects vagina and cunnus hyperraemia disappear or obviously alleviate, and purulent leukorrhea transfers white to, only a small amount of rare white leukorrhea, and stink disappears;
(3) effectively vagina and cunnus hyperraemia alleviate, and the leukorrhea amount reduces, and it is shallow that look changes, and stink obviously alleviates;
(4) invalid sign is little with preceding no change of treatment or variation.
4, treatment results
30 examples, women, 19-35 year wherein, 28 examples, 45 years old 1 example, 50 years old 1 example.5 examples of fully recovering, cure rate is 83%, produce effects 4 examples, obvious effective rate is 13%, effective 1 example, efficient is 4%.Total effective rate is 100%.
People's body surface infects, as pustular eruption, and herpes zoster, tinea pedis infection etc. are cleaned or the soak affected part with disinfectant of the present invention, 1-2 week, treat 57 examples, male 25 examples, women's 32 examples, 52 examples of fully recovering, produce effects 5 examples, total effective rate is 100%.
The advantage of disinfectant for external use:
1, this disinfectant adopts Chinese and Western medicine optimum organization, and sterilizing power is strong, fast, and wider antimicrobial spectrum is arranged.
2, this disinfectant is specifically designed to the sterilization of people's body surface, kills the pathogenic microorganisms on the body surface or suppresses viral growth and breeding, prevents the infringement of pathogene to body surface or infection site, can reach the effect of prevention and treatment;
3, this disinfectant contains plant gel class material, can make washing agent, cleans infection site, quickens the reparation of damage and the effect of protection skin, is the collection sterilization, and treatment is cleaned and skin care is the novel body-building disinfectant of one;
4, this disinfectant nonirritant, corrosivity and toxicity; Stability might as well;
5, mature production technology, equipment investment is few, and raw material is easy to get, and price is suitable.
(4) embodiment
Embodiment one
Disinfectant for external use is to be mixed and be mixed with by purslane extract 15kg, common cnidium fruit P.E 15kg, shrubby sophora extract 10kg, aloe extract 10kg, Ciprofloxacin lactate 0.006kg, is powder.
Embodiment two
The washing lotion formulation of disinfectant for external use be by:
Purslane extract 15kg, common cnidium fruit P.E 15kg, shrubby sophora extract 10kg, aloe extract 10kg, Ciprofloxacin lactate 0.006kg add 949.994kg distilled water and are mixed with.
Specification:
(1) washing lotion formulation 200mL/ bottle, 500mL/ bottle
(2) powder 6g/ bag, 10g/ bag.
Claims (3)
1, disinfectant for external use, be to mix by Chinese medical extract and Western medicine Ciprofloxacin lactate to be mixed with, it is characterized in that described Chinese medical extract comprises Chinese medicine purslane extract, common cnidium fruit P.E, shrubby sophora extract, aloe extract, its compatibility is: purslane extract 7.5-30kg, common cnidium fruit P.E 7.5-30kg, shrubby sophora extract 5-20kg, aloe extract 5-20kg, Ciprofloxacin lactate 0.002-0.009kg.
2, disinfectant for external use according to claim 1 is characterized in that being mixed with by purslane extract 15kg, common cnidium fruit P.E 15kg, shrubby sophora extract 10kg, aloe extract 10kg, Ciprofloxacin lactate 0.006kg.
3, disinfectant for external use according to claim 2 is characterized in that adding 949.994kg distilled water, makes washing lotion.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB031333915A CN1191066C (en) | 2003-05-27 | 2003-05-27 | Externally-used disinfector |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB031333915A CN1191066C (en) | 2003-05-27 | 2003-05-27 | Externally-used disinfector |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1462584A true CN1462584A (en) | 2003-12-24 |
| CN1191066C CN1191066C (en) | 2005-03-02 |
Family
ID=29748499
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB031333915A Expired - Fee Related CN1191066C (en) | 2003-05-27 | 2003-05-27 | Externally-used disinfector |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1191066C (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101543467B (en) * | 2009-04-01 | 2010-12-29 | 完美(中国)日用品有限公司 | Aloe gel and preparation method thereof |
| CN102986666A (en) * | 2012-11-29 | 2013-03-27 | 陈容太 | Chemical sanitizer |
| CN102986665A (en) * | 2012-11-29 | 2013-03-27 | 陈容太 | Method for preparing chemical sanitizer |
| CN103690698A (en) * | 2013-11-26 | 2014-04-02 | 安徽三超药业有限公司 | Broad-spectrum antibacterial cream |
| CN107853332A (en) * | 2017-09-20 | 2018-03-30 | 连云港柘达消毒科技有限公司 | A kind of environment-friendly high-efficiency disinfectant |
-
2003
- 2003-05-27 CN CNB031333915A patent/CN1191066C/en not_active Expired - Fee Related
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101543467B (en) * | 2009-04-01 | 2010-12-29 | 完美(中国)日用品有限公司 | Aloe gel and preparation method thereof |
| CN102986666A (en) * | 2012-11-29 | 2013-03-27 | 陈容太 | Chemical sanitizer |
| CN102986665A (en) * | 2012-11-29 | 2013-03-27 | 陈容太 | Method for preparing chemical sanitizer |
| CN103690698A (en) * | 2013-11-26 | 2014-04-02 | 安徽三超药业有限公司 | Broad-spectrum antibacterial cream |
| CN107853332A (en) * | 2017-09-20 | 2018-03-30 | 连云港柘达消毒科技有限公司 | A kind of environment-friendly high-efficiency disinfectant |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1191066C (en) | 2005-03-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN107802825A (en) | A kind of Traditional Chinese medicine gel composition antibacterial for vaginal mucosa | |
| CN105123816A (en) | Sterilizing and disinfecting liquid for clinical laboratory and preparation method | |
| CN106214573A (en) | A kind of medical disposable hand saver skin disinfectant solution and preparation method thereof | |
| CN107468639A (en) | A kind of gynaecologic antibiotic gel and preparation method thereof | |
| CN101543658B (en) | Cervical cap for preventing and treating cervical erosion and preparation method thereof | |
| CN114028546A (en) | Composite polypeptide sterilization preparation and preparation method and application thereof | |
| CN103933275A (en) | Antibacterial disinfection medicament and preparation method thereof | |
| CN105148059A (en) | Plant oil external liniment capable of repelling mosquitos and preparation method thereof | |
| CN114712482B (en) | Astaxanthin-containing vagina cleaning antibacterial gel and preparation method thereof | |
| CN1524587A (en) | Nursing wet towel using tea plant oil as antibacterial and fungistatic agent and production method thereof | |
| CN1191066C (en) | Externally-used disinfector | |
| CN109602813A (en) | A kind of bacteriostatic gel and preparation method thereof | |
| CN108404111A (en) | One kind is with kidney bean phytolectin inhibitory anti-virus preparation as main component | |
| Vats et al. | Synergistic antimicrobial effect of cow urine and Azadirachta indica on infectious microbes | |
| CN111067971A (en) | Traditional Chinese medicine composition for treating paronychia and using method thereof | |
| CN1189206C (en) | Medicine for curing leuconychia and hand-foot ringworm and preparing method thereof | |
| CN105613612A (en) | Agent for disinfecting intensive care unit and preparation method | |
| CN104645117A (en) | Traditional Chinese medicine disinfectant for clinical laboratory | |
| CN103719167A (en) | Degerming agent specially used for aeromonas hydrophila water body | |
| CN107929170A (en) | A kind of eucalyptus oil shampoo and its preparation method and application of pet | |
| CN1062148C (en) | Compound jiabing ear drops and preparation method thereof | |
| CN101461850B (en) | Application of Chinese medicinal composition in preparing medicament for treating acne | |
| CN1197595C (en) | Chinese medicine preparation for broad-spectrum inflammation relieving, disinfecting, erosion prevention and muscle growing | |
| RU2180221C2 (en) | Method to treat subclinical mastitis in cows | |
| Suresh et al. | Evaluation of Antibacterial Activity of Bacopa Monnieri Extract on Periodontogenic Bacteria–An in-Vitro Study |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |